Martin Zentgraf
Vorstandsvorsitzender bei Desitin Arzneimittel GmbH
Aktive Positionen von Martin Zentgraf
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Desitin Arzneimittel GmbH
 Desitin Arzneimittel GmbH Pharmaceuticals: MajorHealth Technology Desitin Arzneimittel GmbH manufactures pharmaceutical products for neurological and psychiatric illnesses. Its products are geared towards the treatment of epilepsy, migraine and Parkinson's disease. The company was founded in 1919 and is headquartered in Hamburg, Germany. | Vorstandsvorsitzender | 10.10.2011 | - |
Bourne Capital Partners LLC (Private Equity)
 Bourne Capital Partners LLC (Private Equity) Investment ManagersFinance Bourne Capital Partners LLC (Bourne Partners) is a private equity firm founded in 2001 by Banks Bourne. The firm is headquartered in Charlotte, North Carolina. | Berater | 01.01.2022 | - |
Karriereverlauf von Martin Zentgraf
Ausbildung von Martin Zentgraf
| University of Münster | Graduate Degree |
Statistik
International
| Deutschland | 3 |
| Vereinigte Staaten | 2 |
Operativ
| Chief Executive Officer | 1 |
| Consultant / Advisor | 1 |
| Graduate Degree | 1 |
Sektoral
| Consumer Services | 2 |
| Health Technology | 2 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Desitin Arzneimittel GmbH
Desitin Arzneimittel GmbH Pharmaceuticals: MajorHealth Technology Desitin Arzneimittel GmbH manufactures pharmaceutical products for neurological and psychiatric illnesses. Its products are geared towards the treatment of epilepsy, migraine and Parkinson's disease. The company was founded in 1919 and is headquartered in Hamburg, Germany. | Health Technology |
Bourne Capital Partners LLC (Private Equity)
Bourne Capital Partners LLC (Private Equity) Investment ManagersFinance Bourne Capital Partners LLC (Bourne Partners) is a private equity firm founded in 2001 by Banks Bourne. The firm is headquartered in Charlotte, North Carolina. | Finance |
- Börse
- Insiders
- Martin Zentgraf
- Erfahrung
